Assessing the polypharmacology of kinase inhibitors by transcription factor activity profiling
Ended Project Grant Awarded Last action
- Award ID
- R44GM136083
- Recipient
-
Attagene Inc. UEI Z8AYGD59N8U4
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,999,992
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Funding
-
- $2,999,994.00 Federal
- $999,998.00 Non-federal
- Place of performance
- North Carolina, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $999,998 | $0 | |
| Amendment | $999,998 | $999,998 | |
| Original award | $999,998 | $0 |
Quick answers
Who received award R44GM136083?
R44GM136083 was awarded to Attagene Inc. by National Institute of General Medical Sciences (National Institutes of Health) on March 1, 2020.
How much is award R44GM136083 worth?
$3,999,992 has been obligated on R44GM136083: $2,999,994 in federal funding and $999,998 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award